Trial Outcomes & Findings for Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis (NCT NCT03720210)

NCT ID: NCT03720210

Last Updated: 2021-10-11

Results Overview

Thyroid tests

• Recruitment status: TERMINATED
• Study phase: NA
• Target enrollment: 1 participants
• Primary outcome timeframe: 3 - 6 months
• Results posted on: 2021-10-11

Participant Flow

Participant milestones

Measure	RFA Group RFA (Radiofrequency Ablation) RFA: Radiofrequency ablation of a portion of thyroid parenchyma to treat amiodarone-induced thyrotoxicosis
Overall Study STARTED	1
Overall Study COMPLETED	0
Overall Study NOT COMPLETED	1

Reasons for withdrawal

Measure	RFA Group RFA (Radiofrequency Ablation) RFA: Radiofrequency ablation of a portion of thyroid parenchyma to treat amiodarone-induced thyrotoxicosis
Overall Study Lost to Follow-up	1

Baseline Characteristics

Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis

Baseline characteristics by cohort

Measure	RFA Group n=1 Participants RFA RFA: Radiofrequency ablation of a portion of thyroid parenchyma to treat amiodarone-induced thyrotoxicosis
Age, Customized Age 31	1 Participants n=5 Participants
Sex: Female, Male Female	0 Participants n=5 Participants
Sex: Female, Male Male	1 Participants n=5 Participants
Race (NIH/OMB) American Indian or Alaska Native	1 Participants n=5 Participants
Race (NIH/OMB) Asian	0 Participants n=5 Participants
Race (NIH/OMB) Native Hawaiian or Other Pacific Islander	0 Participants n=5 Participants
Race (NIH/OMB) Black or African American	0 Participants n=5 Participants
Race (NIH/OMB) White	0 Participants n=5 Participants
Race (NIH/OMB) More than one race	0 Participants n=5 Participants
Race (NIH/OMB) Unknown or Not Reported	0 Participants n=5 Participants
Region of Enrollment United States	1 participants n=5 Participants

PRIMARY outcome

Timeframe: 3 - 6 months

Population: The one subject enrolled did not return for follow up. Data not collected or analyzed.

Thyroid tests

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 3 - 6 months

Population: The one subject enrolled did not return for follow up. Data not collected or analyzed.

Thyroid tests

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 1 - 2 months

Population: The one subject enrolled did not return for follow up. Data not collected or analyzed.

McGill Pain Questionnaire

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 - 6 months

Population: The one subject enrolled did not return for follow up. Data not collected or analyzed.

Thyroid tests

Outcome measures

Outcome data not reported

Adverse Events

RFA Group

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Marius N. Stan, M.D.

Mayo Clinic

Phone: 507-266-3769

Email: Stan.Marius@mayo.edu

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place